Global Oral Vaccine for Human Supply, Demand and Key Producers, 2023-2029

Global Oral Vaccine for Human Supply, Demand and Key Producers, 2023-2029

The global Oral Vaccine for Human market size is expected to reach $ 3783.3 million by 2029, rising at a market growth of 5.4% CAGR during the forecast period (2023-2029).

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. 

This report studies the global Oral Vaccine for Human production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Vaccine for Human, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Vaccine for Human that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Oral Vaccine for Human total production and demand, 2018-2029, (K Units)

Global Oral Vaccine for Human total production value, 2018-2029, (USD Million)

Global Oral Vaccine for Human production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oral Vaccine for Human consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Oral Vaccine for Human domestic production, consumption, key domestic manufacturers and share

Global Oral Vaccine for Human production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Oral Vaccine for Human production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oral Vaccine for Human production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Oral Vaccine for Human market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Vaccine for Human market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Vaccine for Human Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Oral Vaccine for Human Market, Segmentation by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Global Oral Vaccine for Human Market, Segmentation by Application
Public
Private

Companies Profiled:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Key Questions Answered

1. How big is the global Oral Vaccine for Human market?

2. What is the demand of the global Oral Vaccine for Human market?

3. What is the year over year growth of the global Oral Vaccine for Human market?

4. What is the production and production value of the global Oral Vaccine for Human market?

5. Who are the key producers in the global Oral Vaccine for Human market?

6. What are the growth factors driving the market demand?